These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 19940263

  • 1. Adiponectin: an indispensable molecule in rosiglitazone cardioprotection following myocardial infarction.
    Tao L, Wang Y, Gao E, Zhang H, Yuan Y, Lau WB, Chan L, Koch WJ, Ma XL.
    Circ Res; 2010 Feb 05; 106(2):409-17. PubMed ID: 19940263
    [Abstract] [Full Text] [Related]

  • 2. Cardiomyocyte-derived adiponectin is biologically active in protecting against myocardial ischemia-reperfusion injury.
    Wang Y, Lau WB, Gao E, Tao L, Yuan Y, Li R, Wang X, Koch WJ, Ma XL.
    Am J Physiol Endocrinol Metab; 2010 Mar 05; 298(3):E663-70. PubMed ID: 20028965
    [Abstract] [Full Text] [Related]

  • 3. AdipoRon, the first orally active adiponectin receptor activator, attenuates postischemic myocardial apoptosis through both AMPK-mediated and AMPK-independent signalings.
    Zhang Y, Zhao J, Li R, Lau WB, Yuan YX, Liang B, Li R, Gao EH, Koch WJ, Ma XL, Wang YJ.
    Am J Physiol Endocrinol Metab; 2015 Aug 01; 309(3):E275-82. PubMed ID: 26037251
    [Abstract] [Full Text] [Related]

  • 4. Acute rosiglitazone treatment is cardioprotective against ischemia-reperfusion injury by modulating AMPK, Akt, and JNK signaling in nondiabetic mice.
    Morrison A, Yan X, Tong C, Li J.
    Am J Physiol Heart Circ Physiol; 2011 Sep 01; 301(3):H895-902. PubMed ID: 21666107
    [Abstract] [Full Text] [Related]

  • 5. Adiponectin deficiency is associated with severe polymicrobial sepsis, high inflammatory cytokine levels, and high mortality.
    Uji Y, Yamamoto H, Tsuchihashi H, Maeda K, Funahashi T, Shimomura I, Shimizu T, Endo Y, Tani T.
    Surgery; 2009 May 01; 145(5):550-7. PubMed ID: 19375615
    [Abstract] [Full Text] [Related]

  • 6. Rosiglitazone inhibits monocyte/macrophage adhesion through de novo adiponectin production in human monocytes.
    Tsai JS, Chen CY, Chen YL, Chuang LM.
    J Cell Biochem; 2010 Aug 15; 110(6):1410-9. PubMed ID: 20506517
    [Abstract] [Full Text] [Related]

  • 7. Adiponectin mediates the suppressive effect of rosiglitazone on plasminogen activator inhibitor-1 production.
    Hoo RL, Chow WS, Yau MH, Xu A, Tso AW, Tse HF, Fong CH, Tam S, Chan L, Lam KS.
    Arterioscler Thromb Vasc Biol; 2007 Dec 15; 27(12):2777-82. PubMed ID: 17932317
    [Abstract] [Full Text] [Related]

  • 8. TNF-α antagonism ameliorates myocardial ischemia-reperfusion injury in mice by upregulating adiponectin.
    Gao C, Liu Y, Yu Q, Yang Q, Li B, Sun L, Yan W, Cai X, Gao E, Xiong L, Wang H, Tao L.
    Am J Physiol Heart Circ Physiol; 2015 Jun 15; 308(12):H1583-91. PubMed ID: 25888509
    [Abstract] [Full Text] [Related]

  • 9. Thiazolidinediones reduce pathological neovascularization in ischemic retina via an adiponectin-dependent mechanism.
    Higuchi A, Ohashi K, Shibata R, Sono-Romanelli S, Walsh K, Ouchi N.
    Arterioscler Thromb Vasc Biol; 2010 Jan 15; 30(1):46-53. PubMed ID: 19910632
    [Abstract] [Full Text] [Related]

  • 10. Cardioprotective effects of rosiglitazone are associated with selective overexpression of type 2 angiotensin receptors and inhibition of p42/44 MAPK.
    Molavi B, Chen J, Mehta JL.
    Am J Physiol Heart Circ Physiol; 2006 Aug 15; 291(2):H687-93. PubMed ID: 16582019
    [Abstract] [Full Text] [Related]

  • 11. Obese mice lacking inducible nitric oxide synthase are sensitized to the metabolic actions of peroxisome proliferator-activated receptor-gamma agonism.
    Dallaire P, Bellmann K, Laplante M, Gélinas S, Centeno-Baez C, Penfornis P, Peyot ML, Latour MG, Lamontagne J, Trujillo ME, Scherer PE, Prentki M, Deshaies Y, Marette A.
    Diabetes; 2008 Aug 15; 57(8):1999-2011. PubMed ID: 18458147
    [Abstract] [Full Text] [Related]

  • 12. Adiponectin exerts cardioprotection against ischemia/reperfusion injury partially via calreticulin mediated anti-apoptotic and anti-oxidative actions.
    Sun Y, Zhao D, Yang Y, Gao C, Zhang X, Ma Z, Jiang S, Zhao L, Chen W, Ren K, Yi W, Gao F.
    Apoptosis; 2017 Jan 15; 22(1):108-117. PubMed ID: 27757734
    [Abstract] [Full Text] [Related]

  • 13. Essential role of caveolin-3 in adiponectin signalsome formation and adiponectin cardioprotection.
    Wang Y, Wang X, Jasmin JF, Lau WB, Li R, Yuan Y, Yi W, Chuprun K, Lisanti MP, Koch WJ, Gao E, Ma XL.
    Arterioscler Thromb Vasc Biol; 2012 Apr 15; 32(4):934-42. PubMed ID: 22328772
    [Abstract] [Full Text] [Related]

  • 14. Cardioprotection mediated by rosiglitazone, a peroxisome proliferator-activated receptor gamma ligand, in relation to nitric oxide.
    Gonon AT, Bulhak A, Labruto F, Sjöquist PO, Pernow J.
    Basic Res Cardiol; 2007 Jan 15; 102(1):80-9. PubMed ID: 16900441
    [Abstract] [Full Text] [Related]

  • 15. Rosiglitazone, a PPARγ agonist, ameliorates palmitate-induced insulin resistance and apoptosis in skeletal muscle cells.
    Meshkani R, Sadeghi A, Taheripak G, Zarghooni M, Gerayesh-Nejad S, Bakhtiyari S.
    Cell Biochem Funct; 2014 Dec 15; 32(8):683-91. PubMed ID: 25431031
    [Abstract] [Full Text] [Related]

  • 16. Impaired mitochondrial biogenesis due to dysfunctional adiponectin-AMPK-PGC-1α signaling contributing to increased vulnerability in diabetic heart.
    Yan W, Zhang H, Liu P, Wang H, Liu J, Gao C, Liu Y, Lian K, Yang L, Sun L, Guo Y, Zhang L, Dong L, Lau WB, Gao E, Gao F, Xiong L, Wang H, Qu Y, Tao L.
    Basic Res Cardiol; 2013 May 15; 108(3):329. PubMed ID: 23460046
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Induced adipocyte cell-sheet ameliorates cardiac dysfunction in a mouse myocardial infarction model: a novel drug delivery system for heart failure.
    Imanishi Y, Miyagawa S, Maeda N, Fukushima S, Kitagawa-Sakakida S, Daimon T, Hirata A, Shimizu T, Okano T, Shimomura I, Sawa Y.
    Circulation; 2011 Sep 13; 124(11 Suppl):S10-7. PubMed ID: 21911798
    [Abstract] [Full Text] [Related]

  • 20. Pioglitazone limits myocardial infarct size, activates Akt, and upregulates cPLA2 and COX-2 in a PPAR-γ-independent manner.
    Birnbaum Y, Long B, Qian J, Perez-Polo JR, Ye Y.
    Basic Res Cardiol; 2011 May 13; 106(3):431-46. PubMed ID: 21360043
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.